These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9548401)

  • 1. Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma.
    Li Q; Milo R; Panitch H; Swoveland P; Bever CT
    Eur J Pharmacol; 1998 Jan; 342(2-3):303-10. PubMed ID: 9548401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
    Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
    Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
    Duda PW; Schmied MC; Cook SL; Krieger JI; Hafler DA
    J Clin Invest; 2000 Apr; 105(7):967-76. PubMed ID: 10749576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
    de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
    J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine production in T lymphocyte-microglia interaction is attenuated by glatiramer acetate: a mechanism for therapeutic efficacy in multiple sclerosis.
    Chabot S; Yong FP; Le DM; Metz LM; Myles T; Yong VW
    Mult Scler; 2002 Aug; 8(4):299-306. PubMed ID: 12166500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of glatiramer acetate on superantigen- and mitogen-induced T-cell stimulation in vitro.
    Schmidt S; Balzer S; Nüllen C; Schmidt M; Pohl C; von Rücker A; Klockgether T
    Mult Scler; 2002 Aug; 8(4):307-9. PubMed ID: 12166501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein.
    Dabbert D; Rösner S; Krämer M; Schöll U; Tumani H; Mäder M; Weber F
    Neurosci Lett; 2000 Aug; 289(3):205-8. PubMed ID: 10961665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate.
    D Alessandro J; Garofalo K; Zhao G; Honan C; Duffner J; Capila I; Fier I; Kaundinya G; Kantor D; Ganguly T
    CNS Neurol Disord Drug Targets; 2017; 16(6):714-723. PubMed ID: 28240190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effects of copolymer-1 and interferon beta-1b on the immune response to myelin basic protein.
    Milo R; Panitch H
    J Neuroimmunol; 1995 Sep; 61(2):185-93. PubMed ID: 7593554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
    Arnon R; Aharoni R
    Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells.
    Strengell M; Lehtonen A; Matikainen S; Julkunen I
    J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells.
    Li QQ; Burt DR; Bever CT
    J Neurochem; 2001 Jun; 77(5):1208-17. PubMed ID: 11389171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis.
    Zhang J; Hutton G; Zang Y
    Clin Ther; 2002 Dec; 24(12):1998-2021. PubMed ID: 12581542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate: mechanisms of action in multiple sclerosis.
    Schrempf W; Ziemssen T
    Autoimmun Rev; 2007 Aug; 6(7):469-75. PubMed ID: 17643935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.